The approximately 1,600-square-foot space will support the company’s drug discovery operations and will include a laboratory, fish facility, and offices, increasing Znomics’s current facilities by one-third. The company expects to occupy the additional space in March 2008.
Richard Sessions, CEO of Znomics, said: “This is a state-of-the-art facility that enables us to expand and advance our research on disease assays and models, compound screening, and drug discovery. This new on-campus facility is centrally located and provides us with convenient access to a vibrant scientific and educational community.”